David Alexander Brown

This study identifies an APOE4-specific cerebrospinal fluid proteome signature using machine learning, independent of Alzheimer's disease diagnosis and associated with increased risk of cognitive impairment.

This review evaluates GDF15's neuroprotective role and biomarker potential in neurodegeneration and neurotrauma, highlighting its upregulation and therapeutic benefits in preclinical models.

This review evaluates estrogen and estrogenic compounds' neuroprotective effects in spinal cord injury, finding they reduce inflammation and improve functional outcomes.

This study uses AI-driven meta-analysis of brain gene expression data to identify novel gene candidates and highlights mitochondrial dysfunction in Alzheimer's disease.

The paper identifies EBV latency III stage as a therapeutic target for MS by linking MS risk SNPs to EBV transcription factors and miRNAs.